Adolphe Allen, Cook Linda S, Huang Xun
Department of Internal Medicine, University of New Mexico, 7801 Academy Rd NE, Albuquerque, NM 87109, USA.
Mayo Clin Proc. 2009 Mar;84(3):221-8. doi: 10.4065/84.3.221.
To describe the association between intima-media thickness (IMT) and metabolic syndrome (MetS) and to examine if the addition of IMT to a traditional MetS definition adds value to the assessment of predicted cardiovascular disease (CVD) risk in a large multiethnic population.
In this cross-sectional study, carotid IMT was measured in 2268 men and women as part of a wellness physical examination between August 1, 2000, and October 1, 2001. The wellness examination included a fasting lipid panel, physical examination, and medical history. Mean IMT was described by sex, ethnicity, and the MetS. Predicted risk for CVD was determined with IMT as a component of the diagnostic criteria for MetS.
Intima-media thickness increased with each additional component of the MetS, increasing from 0.516 mm for 0 components to 0.688 mm for 4 or more components (P<.001). In each ethnic group (non-Hispanic whites, blacks, Hispanics, and Asians), those with the MetS had higher mean IMT (increased by 0.084 mm to 0.134 mm) than those without MetS. The addition of IMT as a "new" component in the diagnosis of MetS allowed us to identify 78 (3.4%) participants who were not previously diagnosed as having MetS but who had a high 10-year estimated risk of MetS as measured by the Framingham risk score (11.67%).
The addition of IMT to the traditional criteria for the diagnosis of the MetS may help identify individuals who otherwise would not have been identified to be at high risk of CVD.
描述内膜中层厚度(IMT)与代谢综合征(MetS)之间的关联,并研究在传统MetS定义中加入IMT是否能为评估大型多民族人群的心血管疾病(CVD)预测风险增加价值。
在这项横断面研究中,2000年8月1日至2001年10月1日期间,对2268名男性和女性进行了颈动脉IMT测量,作为健康体检的一部分。健康体检包括空腹血脂检查、体格检查和病史询问。按性别、种族和MetS描述平均IMT。将IMT作为MetS诊断标准的一个组成部分来确定CVD的预测风险。
MetS的每个额外组成部分都会使内膜中层厚度增加,从0个组成部分时的0.516毫米增加到4个或更多组成部分时的0.688毫米(P<0.001)。在每个种族群体(非西班牙裔白人、黑人、西班牙裔和亚洲人)中,患有MetS的人的平均IMT高于未患MetS的人(增加了0.084毫米至0.134毫米)。在MetS诊断中加入IMT作为“新”组成部分,使我们能够识别出78名(3.4%)之前未被诊断为患有MetS但根据弗雷明汉风险评分测量有较高的10年MetS估计风险(11.67%)的参与者。
在传统的MetS诊断标准中加入IMT可能有助于识别那些原本不会被确定为有高CVD风险的个体。